N.Y.C. Admin. Code § 14-176: § 14-176 Opioid antagonist report.

a. For the purpose of this section, the following terms have the following meanings:

Officer. The term "officer" has the same meaning as defined under section 14-174.

Opioid antagonist. The term "opioid antagonist" means naloxone, narcan or other medication approved by the New York state department of health and the federal food and drug administration that, when administered, negates or neutralizes in whole or in part the pharmacological effects of an opioid in the human body.

b. Beginning with the calendar quarter starting on January 1, 2019, the commissioner shall submit to the speaker of the council and the department of health and mental hygiene, within 25 days of the end of each quarter and post to the department's website five days thereafter, a report relating to opioid antagonists, which shall include:

1. The number of opioid antagonists the department has available for use in reversing the effects of a heroin or opioid overdose, disaggregated by patrol borough;

2. The number of officers trained in the department to administer opioid antagonists to overdose victims, disaggregated by patrol borough; and

3. The number of times in the quarter that an officer administered an opioid antagonists to an overdose victim, disaggregated by patrol borough and by the way in which the opioid antagonist was administered to such overdose victim, such as by syringe injection or nasal atomizer. Such number shall be expressed in both absolute terms and as a percentage of all administrations.

c. The report created pursuant to this section shall be provided within 30 days of the end of the quarter to which the report corresponds. Where necessary, the department may use preliminary data to prepare the required report. If preliminary data is used, the department shall include an acknowledgment that such preliminary data is non-final and subject to change.

(L.L. 2018/130, 6/26/2018, eff. 8/25/2018)